A Bioavailability Study of Two Different PEG-rhGH Preparations.

Exclusion Criteria

• •Subjects with a history of hypersensitivity reactions or clinically significant hypersensitivity reactions to drugs containing;
• •Subjects with a clear history of disorders of the central nervous system, cardiovascular system, digestive system, respiratory system, urinary system, blood system, metabolic system, etc., or other diseases deemed unsuitable for participation in the trials by the investigators;
• •Subjects with severe infection, severe trauma, or major surgery prior to screening;
• •Subjects who have received blood transfusions, had blood donors, or lost blood before screening;
• •Subjects who have positive results of human immunodeficiency virus antibodies (HIV-Ab), or hepatitis B surface antigen (HBsAg), or hepatitis C virus antibodies (HCV-Ab), or syphilis specific antibodies (TPPA);
• •Subjects who have participated in clinical trials for medication or medical device prior to screening;etc.